PSA screening for prostate cancer

被引：4
|
作者：
Wilt, Timothy J. [1 ,2 ,3 ]
Dahm, Philipp [4 ,5 ]
机构：
[1] Minneapolis Vet Affairs Hlth Care Syst, Gen Internal Med, Minneapolis, MN 55417 USA
[2] Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA
[3] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[4] Univ Florida, Coll Med, Malcom Randall VA Med Ctr, Gainesville, FL USA
[5] Univ Florida, Coll Med, Dept Urol, Gainesville, FL USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 348卷
关键词：
RADICAL PROSTATECTOMY; BENEFITS;
D O I：
10.1136/bmj.g2559
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] What are the operating characteristics of PSA screening for prostate cancer?
    Robert E Reiter
    Benjamin Shurtleff
    [J]. Nature Clinical Practice Urology, 2006, 3 : 74 - 75
  • [42] Reconsidering Prostate Cancer Mortality - The Future of PSA Screening
    Welch, H. Gilbert
    Albertsen, Peter C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16): : 1557 - 1563
  • [43] Performance characteristics of PSA density for prostate cancer screening
    Sotelo, RJ
    Novoa, J
    Karam, O
    Mora, KE
    Perez, H
    Keklikian, W
    De Andrade, R
    Carmona, O
    Loeb, S
    Catalona, WJ
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 479 - 479
  • [44] PSA screening reduces prostate cancer mortality Reply
    Dr Burns
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (01): : 8 - 8
  • [45] Genetically adjusted PSA levels for prostate cancer screening
    Linda Kachuri
    Thomas J. Hoffmann
    Yu Jiang
    Sonja I. Berndt
    John P. Shelley
    Kerry R. Schaffer
    Mitchell J. Machiela
    Neal D. Freedman
    Wen-Yi Huang
    Shengchao A. Li
    Ryder Easterlin
    Phyllis J. Goodman
    Cathee Till
    Ian Thompson
    Hans Lilja
    Stephen K. Van Den Eeden
    Stephen J. Chanock
    Christopher A. Haiman
    David V. Conti
    Robert J. Klein
    Jonathan D. Mosley
    Rebecca E. Graff
    John S. Witte
    [J]. Nature Medicine, 2023, 29 : 1412 - 1423
  • [46] Prostate Cancer - PSA Screening reduces Risk of Metastases
    Ohlmann, C. -H.
    [J]. AKTUELLE UROLOGIE, 2013, 44 (04) : 256 - U92
  • [47] PSA AS A SCREENING-TEST FOR PROSTATE-CANCER
    CRAWFORD, ED
    DEANTONI, EP
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1993, 20 (04) : 637 - 646
  • [48] PSA and prostate cancer screening: The challenge of the new millennium
    Bjartell, Anders
    [J]. EUROPEAN UROLOGY, 2007, 52 (05) : 1284 - 1286
  • [49] Number needed to harm in prostate cancer screening with PSA
    Perini, P.
    Boyle, P.
    Koechlin, A.
    Ruffion, A.
    Autier, P.
    Boniol, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S321 - S321
  • [50] PSA testing: an evolving relationship with prostate cancer screening
    Constantinou, J
    Feneley, MR
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 6 - 13
12345